Massimiliano Cazzato

2.2k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

Massimiliano Cazzato is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Massimiliano Cazzato has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 7 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Massimiliano Cazzato's work include Rheumatoid Arthritis Research and Therapies (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Lupus Erythematosus Research (7 papers). Massimiliano Cazzato is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Lupus Erythematosus Research (7 papers). Massimiliano Cazzato collaborates with scholars based in Italy, United Kingdom and Belarus. Massimiliano Cazzato's co-authors include Marco Sebastiani, Dilia Giuggioli, Claudio Michelassi, Alessandro Antonelli, Anna Linda Zignego, Clodoveo Ferri, Stefano Bombardieri, G. Longombardo, Rodolfo Puccini and Clodoveo Ferri and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and Medicine.

In The Last Decade

Massimiliano Cazzato

23 papers receiving 1.3k citations

Hit Papers

Systemic Sclerosis 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Systemic Sclerosis
    2002 551 citations Clodoveo Ferri, Gabriele Valentini et al. Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimiliano Cazzato Italy 12 647 523 359 308 287 25 1.4k
Cándido Díaz‐Lagares Spain 19 224 0.3× 704 1.3× 346 1.0× 261 0.8× 277 1.0× 25 1.5k
Soledad Retamozo Spain 22 194 0.3× 475 0.9× 378 1.1× 286 0.9× 318 1.1× 55 1.7k
R. Pérez-Álvarez Spain 19 207 0.3× 599 1.1× 343 1.0× 164 0.5× 488 1.7× 25 1.6k
M. Pérez-de-Lis Spain 17 167 0.3× 411 0.8× 309 0.9× 184 0.6× 263 0.9× 20 1.2k
Ashima Makol United States 25 251 0.4× 872 1.7× 209 0.6× 70 0.2× 664 2.3× 81 1.6k
Muriel Elhaï France 22 940 1.5× 545 1.0× 346 1.0× 35 0.1× 490 1.7× 59 1.6k
M J Cuadrado United Kingdom 13 189 0.3× 814 1.6× 233 0.6× 79 0.3× 253 0.9× 21 1.4k
Chi Hung To China 24 282 0.4× 1.5k 3.0× 345 1.0× 234 0.8× 106 0.4× 45 2.0k
Geneviève Depresseux Belgium 15 223 0.3× 654 1.3× 127 0.4× 151 0.5× 124 0.4× 23 1.1k
M. Taraborelli Italy 19 229 0.4× 693 1.3× 312 0.9× 65 0.2× 64 0.2× 37 978

Countries citing papers authored by Massimiliano Cazzato

Since Specialization
Citations

This map shows the geographic impact of Massimiliano Cazzato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimiliano Cazzato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimiliano Cazzato more than expected).

Fields of papers citing papers by Massimiliano Cazzato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimiliano Cazzato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimiliano Cazzato. The network helps show where Massimiliano Cazzato may publish in the future.

Co-authorship network of co-authors of Massimiliano Cazzato

This figure shows the co-authorship network connecting the top 25 collaborators of Massimiliano Cazzato. A scholar is included among the top collaborators of Massimiliano Cazzato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimiliano Cazzato. Massimiliano Cazzato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baldi, Caterina, Stefano Gentileschi, Francesca Li Gobbi, et al.. (2025). Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre study. Clinical and Experimental Medicine. 25(1). 50–50. 1 indexed citations
2.
Benucci, Maurizio, Marco Bardelli, Massimiliano Cazzato, et al.. (2024). Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65). Journal of Personalized Medicine. 14(7). 712–712. 1 indexed citations
3.
Gentileschi, Stefano, Carla Gaggiano, Arianna Damiani, et al.. (2024). Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort. Clinical and Experimental Medicine. 24(1). 62–62. 3 indexed citations
4.
Manfredi, Andreina, Vincenzo Venerito, Massimiliano Cazzato, et al.. (2024). Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences. Journal of Clinical Medicine. 13(21). 6508–6508.
5.
Sebastiani, Marco, Vincenzo Venerito, Stefano Gentileschi, et al.. (2023). Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study. Journal of Clinical Medicine. 12(22). 7041–7041. 7 indexed citations
6.
Convertino, Irma, Massimiliano Cazzato, Rosa Gini, et al.. (2023). Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy. Frontiers in Pharmacology. 14. 1244486–1244486.
7.
Benucci, Maurizio, Marco Bardelli, Massimiliano Cazzato, et al.. (2023). ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice. Journal of Personalized Medicine. 13(9). 1303–1303. 4 indexed citations
8.
9.
Convertino, Irma, Rosa Gini, Massimiliano Cazzato, et al.. (2021). Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study. Journal of Clinical Medicine. 10(24). 5743–5743. 3 indexed citations
10.
Convertino, Irma, Massimiliano Cazzato, Rosa Gini, et al.. (2021). Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases. Scientific Reports. 11(1). 20314–20314. 4 indexed citations
11.
Convertino, Irma, Ersilia Lucenteforte, Rosa Gini, et al.. (2021). Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons. Clinical and Experimental Rheumatology. 39(4). 753–762. 9 indexed citations
12.
Mazzantini, Maurizio, Rosaria Talarico, M. Doveri, et al.. (2010). Incident Comorbidity Among Patients with Rheumatoid Arthritis Treated or Not with Low-dose Glucocorticoids: A Retrospective Study. The Journal of Rheumatology. 37(11). 2232–2236. 39 indexed citations
13.
Cazzato, Massimiliano, R Neri, Niccolò Possemato, Rodolfo Puccini, & Stefano Bombardieri. (2010). A case of adult periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome associated with endocapillary proliferative glomerulonephritis. Clinical Rheumatology. 32(S1). 33–36. 13 indexed citations
14.
Rossa, Alessandra Della, R Neri, Rosaria Talarico, et al.. (2009). Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy. Clinical Rheumatology. 29(1). 71–81. 15 indexed citations
15.
Antonelli, Alessandro, Clodoveo Ferri, Poupak Fallahi, et al.. (2007). Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. European Journal of Endocrinology. 156(4). 431–437. 73 indexed citations
16.
Sokka, Tuulikki, Hannu Kautiainen, S. Toloza, et al.. (2007). QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Annals of the Rheumatic Diseases. 66(11). 1491–1496. 159 indexed citations
17.
Ferri, Claudio, Dilia Giuggioli, Massimiliano Cazzato, et al.. (2004). HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies.. PubMed. 21(6 Suppl 32). S78–84. 39 indexed citations
18.
Ferri, Clodoveo, Marco Sebastiani, Dilia Giuggioli, et al.. (2004). Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Seminars in Arthritis and Rheumatism. 33(6). 355–374. 350 indexed citations
19.
Ferri, Claudio, Anna Linda Zignego, Dilia Giuggioli, et al.. (2002). HCV and cryoglobulinemic vasculitis.. Cleveland Clinic Journal of Medicine. 69(Suppl_2). SII20–SII20. 20 indexed citations
20.
Ferri, Clodoveo, Gabriele Valentini, Franco Cozzi, et al.. (2002). Systemic Sclerosis. Medicine. 81(2). 139–153. 551 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cándido Díaz‐Lagares Breakdown of academic impact, for papers by Soledad Retamozo Breakdown of academic impact, for papers by R. Pérez-Álvarez Breakdown of academic impact, for papers by M. Pérez-de-Lis Breakdown of academic impact, for papers by Ashima Makol Breakdown of academic impact, for papers by Muriel Elhaï Breakdown of academic impact, for papers by M J Cuadrado Breakdown of academic impact, for papers by Chi Hung To Breakdown of academic impact, for papers by Geneviève Depresseux Breakdown of academic impact, for papers by M. Taraborelli
Rankless by CCL
2026